Literature DB >> 24511010

3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.

Il Ki Hong1, Seog Young Kim, Jin Hwa Chung, Seung Jin Lee, Seung Jun Oh, Sang Ju Lee, Jungsu Oh, Jin-Sook Ryu, Tae Won Kim, Deog Yoon Kim, Dae Hyuk Moon.   

Abstract

AIM: We aimed to investigate whether 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) positron emission tomography (PET) can estimate thymidine kinase 1 (TK1) activity after thymidylate synthase (TS) inhibition by 5-fluorouracil (5-FU) in a mouse tumor model.
MATERIALS AND METHODS: Nude mice with HT29 tumors were injected with phosphate-buffered saline or 5-FU (16.7 or 50 mg/kg). Twenty-four hours later, 2-hour dynamic images were acquired after injection of [(18)F]FLT. In another group of mice with HT29 cells, static PET images were obtained 110 min after [(18)F]FLT injection.
RESULTS: Kinetic parameters related to [(18)F]FLT retention increased significantly, whereas the de-phosphorylation of [(18)F]FLT monophosphate decreased significantly. The standardized uptake value (SUVmean) of HT29 tumors correlated significantly with the net influx constant and the distribution volume for phosphorylated [(18)F]FLT. There was a significant correlation between the tumor SUVmean and TK1 activity.
CONCLUSION: SUVmean at 110-120 min after [(18)F]FLT, can quantitatively evaluate kinetic parameters and TK1 activity after TS inhibition.

Entities:  

Keywords:  3’-deoxy-3’-[18F]fluorothymidine; 5-fluorouracil; positron emission tomography; thymidine kinase; thymidylate synthase

Mesh:

Substances:

Year:  2014        PMID: 24511010

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studies.

Authors:  Mette Munk Jensen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

2.  Response Monitoring with [18F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.

Authors:  Sandra Heskamp; Linda Heijmen; Danny Gerrits; Janneke D M Molkenboer-Kuenen; Edwin G W Ter Voert; Kathrin Heinzmann; Davina J Honess; Donna-Michelle Smith; John R Griffiths; Sabrina Doblas; Ralph Sinkus; Peter Laverman; Wim J G Oyen; Arend Heerschap; Otto C Boerman
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

3.  Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.

Authors:  Xiao Chen; Yizeng Yang; Ian Berger; Urooj Khalid; Akash Patel; Jenny Cai; Michael D Farwell; Corey Langer; Charu Aggarwal; Steven M Albelda; Sharyn I Katz
Journal:  Oncotarget       Date:  2017-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.